Specifically, it reversed enhancement in tumor growth, mass, and expression of downstream genes (NUP62, NUP93, and NUP98) (Figure 3C, D), accompanied by modulation of NPC numbers and Ki-67 or CD31 labeling index (Figure 3E, F). This evidence concerns the gene PECAM1 and neoplasm.